Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study

Similar Items

• Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)
  by: Doyle Mark, et al.
  Published: (2013-01-01)
• Decisions Informed by Computing Entities (DICE) to improve prognostic value of myocardial perfusion imaging: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study
  by: Doyle Mark, et al.
  Published: (2012-02-01)
• TIMI frame count and adverse events in women with no obstructive coronary disease: a pilot study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
  by: John W Petersen, et al.
  Published: (2014-01-01)
• Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
  by: Sharaf Barry L, et al.
  Published: (2008-03-01)
• Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study.
  by: C Noel Bairey Merz, et al.
  Published: (2018-01-01)